Genmab A/S (GMAB)
NASDAQ: GMAB
· Real-Time Price · USD
28.84
-0.61 (-2.07%)
At close: Sep 25, 2025, 3:59 PM
28.82
-0.07%
After-hours: Sep 25, 2025, 04:50 PM EDT
-2.07% (1D)
| Bid | 21.06 |
| Market Cap | 18.2B |
| Revenue (ttm) | 22.78B |
| Net Income (ttm) | 7.44B |
| EPS (ttm) | 1.93 |
| PE Ratio (ttm) | 14.94 |
| Forward PE | 2.03 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 37.01 |
| Volume | 1,792,203 |
| Avg. Volume (20D) | 1,253,834 |
| Open | 29.25 |
| Previous Close | 29.45 |
| Day's Range | 28.60 - 29.36 |
| 52-Week Range | 17.23 - 29.52 |
| Beta | 0.80 |
| Ex-Dividend Date | n/a |
About GMAB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GMAB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GMAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGenmab A/S is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+4.6%
Genmab shares are trading higher after the company...
Unlock content with
Pro Subscription
1 month ago
+5.49%
Genmab shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY25 sales guidance.
